EMA — authorised 27 February 2002
- Marketing authorisation holder: LEO PHARMA A/S
- Status: approved
EMA authorised Prograf on 27 February 2002
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 27 February 2002.
LEO PHARMA A/S holds the EU marketing authorisation.